GlaxoSmithKline has once again topped a league table that measures the major pharmaceuticals companies’ efforts in enabling people in developing countries to get the drugs they need, while rivals Pfizer and Sanofi have slipped down the rankings.
The British government has been encouraged to put more effort into supporting “scale-ups” companies, rather than simply focusing on smaller startups.
Big tobacco, long accused of complicity in smuggling, is under close scrutiny as it emerges that one of the world’s largest cigarette firms has been fined for oversupplying foreign markets.
Royal Bank of Scotland faces a fine of tens of millions of pounds as early as this week over the collapse of its IT systems that locked millions of customers out of their accounts for days.
They liked to refer to themselves as “the A-team”, “the players” and “the three musketeers”, regarding anyone outside their private group as “numpties”.
Only 50 years ago, St Paul’s was still London’s tallest building: the capital’s skyline has become so overwhelmed with glass and steel towers since then that it’s easy to forget.
Plunging oil prices have triggered merger talks among London’s shipping and offshore brokers, with key companies including Clarkson, Icap and Howe Robinson all in discussions.
It says something about the diminished expectations that the reaction to the latest growth figures for Germany and France was one of relief.
Next year it will be a decade since Royal Bank of Scotland embarked on its near-fatal acquisition of the worst pieces of Dutch bank ABN Amro.
Standard Chartered is at risk of having its rating cut by Standard & Poor's, it was revealed today.
Barclays is preparing to scale back its global ambitions by selling off its once-prized African operations.